Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-15 Sale |
2021-12-17 5:20 pm |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
28,751 | $13 | $373,763 | 271,489 (Direct) |
View |
| 2021-12-13 Purchase |
2021-12-15 5:21 pm |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
8,000 | $11.86 | $94,880 | 268,380 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 6:42 pm |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
28,751 | $15.88 | $456,532 | 196,489 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-06 6:02 pm |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $30.96 | $464,350 | 137,610 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 4:53 pm |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $36.69 | $550,283 | 167,610 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 7:17 pm |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
17,000 | $41.68 | $708,493 | 211,546 (Direct) |
View |
| 2021-08-26 Sale |
2021-08-30 5:16 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
7,714 | $35.75 | $275,787 | 232,970 (Direct) |
View |
| 2021-08-25 Sale |
2021-08-27 8:02 pm |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $33.34 | $277,827 | 264,329 (Direct) |
View |
| 2021-08-13 Sale |
2021-08-17 4:44 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
2,286 | $35.07 | $80,161 | 250,324 (Direct) |
View |
| 2021-08-05 Sale |
2021-08-09 4:26 pm |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $31.09 | $466,394 | 167,610 (Direct) |
View |
| 2021-07-27 Sale |
2021-07-29 7:27 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
20,000 | $35.47 | $709,380 | 209,380 (Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 5:41 pm |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $27.47 | $412,107 | 182,610 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 6:24 pm |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $32.44 | $486,622 | 197,610 (Direct) |
View |
| 2021-05-25 Sale |
2021-05-27 5:03 pm |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $34.27 | $285,537 | 272,662 (Direct) |
View |
| 2021-05-07 Sale |
2021-05-11 6:46 pm |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
10,000 | $40.82 | $408,192 | 229,380 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-15 Option Award |
2022-02-17 7:12 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:11 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:09 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO |
327,900 | $0 | 327,900 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:08 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:07 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:11 pm |
N/A 2032-01-02 |
Prelude Therapeutics Inc | PRLD | Sandor Victor Director |
11,206 | $0 | 11,206 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:20 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
28,751 | $0 | 271,489 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:20 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
25,735 | $12.85 | 271,489 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:20 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
3,016 | $1.89 | 271,489 (Direct) |
View |
| 2021-12-13 Option Award |
2021-12-14 5:37 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
5,000 | $12.28 | 8,000 (Direct) |
View |
| 2021-12-13 Option Award |
2021-12-14 5:36 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna President, CEO |
8,000 | $12.13 | 2,580,722 (Direct) |
View |
| 2021-11-29 Option Award |
2021-12-01 6:00 pm |
N/A 2031-11-28 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
180,000 | $0 | 180,000 (Direct) |
View |
Ownership |
2021-12-01 5:56 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
0 | $0 | 3,000 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 6:42 pm |
N/A 2030-09-01 |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
28,751 | $0 | 196,489 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 6:42 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
28,751 | $12.85 | 196,489 (Direct) |
View |
| 2021-10-13 Option Award |
2021-10-14 6:56 pm |
N/A 2031-10-12 |
Prelude Therapeutics Inc | PRLD | Sandor Victor Director |
8,022 | $0 | 8,022 (Direct) |
View |
| 2021-10-05 Exercise |
2021-10-06 6:02 pm |
N/A 2029-07-17 |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $0 | 137,610 (Direct) |
View |
| 2021-10-05 Exercise |
2021-10-06 6:02 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $1.89 | 137,610 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 4:53 pm |
N/A 2029-07-17 |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $0 | 167,610 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 4:53 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $1.89 | 167,610 (Direct) |
View |
| 2021-09-02 Exercise |
2021-09-07 7:17 pm |
N/A 2030-09-01 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
17,000 | $0 | 211,546 (Direct) |
View |
| 2021-09-02 Exercise |
2021-09-07 7:17 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
17,000 | $12.85 | 211,546 (Direct) |
View |
| 2021-08-26 Exercise |
2021-08-30 5:16 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
7,714 | $1.43 | 232,970 (Direct) |
View |
| 2021-08-26 Exercise |
2021-08-30 5:16 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
7,714 | $0 | 232,970 (Direct) |
View |
| 2021-08-25 Exercise |
2021-08-27 8:02 pm |
N/A 2029-08-06 |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $0 | 264,329 (Direct) |
View |
| 2021-08-25 Exercise |
2021-08-27 8:02 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $1.89 | 264,329 (Direct) |
View |
| 2021-08-13 Exercise |
2021-08-17 4:44 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
1,728 | $1.43 | 250,324 (Direct) |
View |
| 2021-08-13 Exercise |
2021-08-17 4:44 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
2,286 | $0 | 250,324 (Direct) |
View |
| 2021-08-13 Exercise |
2021-08-17 4:44 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
558 | $1.89 | 250,324 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-09 4:26 pm |
N/A 2029-07-17 |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $0 | 167,610 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-09 4:26 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $1.89 | 167,610 (Direct) |
View |
| 2021-07-27 Exercise |
2021-07-29 7:27 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
20,000 | $1.43 | 209,380 (Direct) |
View |
| 2021-07-27 Exercise |
2021-07-29 7:27 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
20,000 | $0 | 209,380 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:17 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:16 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna President, CEO |
285,800 | $0 | 285,800 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:14 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:13 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:11 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:09 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
115,650 | $0 | 115,650 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:07 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
95,000 | $0 | 95,000 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 8:30 pm |
N/A 2031-07-18 |
Prelude Therapeutics Inc | PRLD | Babler Martin Director |
36,400 | $0 | 36,400 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 5:41 pm |
N/A 2029-07-17 |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $0 | 182,610 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 5:41 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $1.89 | 182,610 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 5:42 pm |
N/A 2031-06-17 |
Prelude Therapeutics Inc | PRLD | Sandor Victor Director |
23,344 | $0 | 23,344 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 5:41 pm |
N/A 2031-06-17 |
Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director |
23,344 | $0 | 23,344 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 5:40 pm |
N/A 2031-06-17 |
Prelude Therapeutics Inc | PRLD | Dier Mardi Director |
23,344 | $0 | 23,344 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 5:35 pm |
N/A 2031-06-17 |
Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner |
23,344 | $0 | 23,344 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 5:03 pm |
N/A 2031-06-17 |
Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
23,344 | $0 | 23,344 (Indirect) |
View |
| 2021-06-07 Exercise |
2021-06-09 6:24 pm |
N/A 2029-06-16 |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $0 | 197,610 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 6:24 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Mauro David J Chief Medical Officer |
15,000 | $1.89 | 197,610 (Direct) |
View |
| 2021-05-25 Exercise |
2021-05-27 5:03 pm |
N/A 2029-08-06 |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $0 | 272,662 (Direct) |
View |
| 2021-05-25 Exercise |
2021-05-27 5:03 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer |
8,333 | $1.89 | 272,662 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 6:46 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
10,000 | $1.43 | 229,380 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-11 6:46 pm |
N/A 2028-11-12 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
10,000 | $0 | 229,380 (Direct) |
View |